Most U.S. workers commute, and the costs are steep—here are a few ways to save
People who drive to work day in and day out have likely grown weary of hearing about the growth (and then partial reversal) of
Global billionaire tax could yield $250 billion – study
By Leigh Thomas PARIS (Reuters) – Governments should open a new front in the international clampdown on tax evasion with a global minimum tax
Self-made millionaire: The ‘most successful people’ practice this skill—it requires ‘defiance’ and ‘belligerence’
Matt Higgins went from living in “abject poverty” to running boardrooms, he says. The experience taught the self-made millionaire that successful people have one
AirAsia chief Tony Fernandes criticized after posting shirtless massage photo on LinkedIn
AirAsia boss Tony Fernandes has created a firestorm on social media after sharing a photo of himself receiving a massage topless during a management
CEF Weekly Review: Performance Is The Distribution Anchor For Equity CEFs
Welcome to another installment of our CEF Market Weekly Review, where we discuss closed-end fund (“CEF”) market activity from both the bottom-up – highlighting
The 10 Senate seats most likely to flip in 2024
While events on the other side of the world – and the other end of the US Capitol – have dominated recent news, the
US chip curbs give Huawei a chance to fill the Nvidia void in China
By Josh Ye HONG KONG (Reuters) -U.S. measures to limit the export of advanced artificial intelligence (AI) chips to China may create an opening
U.S. chip export ban is ‘great news,’ says partner at Chinese tech investment fund
A partner at a Chinese semiconductor investment fund has welcomed the U.S. government’s ban of certain advanced chip types to be exported to China,
Chinese drug firms backed by global banks found using leopards and pangolins parts, group says
Editor’s Note: Sign up for CNN’s Meanwhile in China newsletter which explores what you need to know about the country’s rise and how it
United Therapeutics Shifts Focus To Tyvaso DPI Amidst Generic Threat (NASDAQ:UTHR)
At a Glance United Therapeutics’ (NASDAQ:UTHR) Q2 performance underscores robust financials with a notable 27.7% YoY revenue increase, fueling investor optimism. On the clinical
Most Read
